From left to right: Sergio Duron, chief scientific officer of Calporta; Jay Lichter, managing director of Avalon Ventures; Tighe Reardon, chief financial officer of Calporta; and Sanford Madigan, CEO of Calporta. Photo courtesy of Calporta Therapeutics Inc.